Patent №
US 9,155,502
Granted
2015-10-13
Filed 2014
Owner
—
Lab
—
AI components
2
nlp · speech
Assignment
None on record
Dataset
AIPD
2023_r1 edition
Application
14453014
Cerebral palsy impaired speech in children and adolescents are effectively treated by administration of a psychostimulant. Low doses of the psychostimulant significantly increases the percentage of correctly pronounced intelligible syllables or words and the ability to more intelligibly communicate. The improvement in speech persists after cessation of or prior to continued psychostimulant treatment.
AI classification
Natural language1.00
Speech0.74
Evolutionary computation0.00
Machine learning0.00
Knowledge representation0.00
AI hardware0.00
Vision0.00
Planning0.00